These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22730651)

  • 21. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.
    Li S; Yin CC; Medeiros LJ; Bueso-Ramos C; Lu G; Lin P
    Am J Clin Pathol; 2012 Jul; 138(1):146-52. PubMed ID: 22706870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
    Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
    Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between RAD51-g135C and XRCC3-C241T polymorphisms and prognosis of inv (16)/ t(16;16) (CBFbeta-MYH11) acute myeloid leukemia].
    Liu L; Yang L; Mi YC; Li JY; Qin TJ; Xu ZF; Zhang Y; Wang JX; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):433-8. PubMed ID: 22213860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China.
    Cheng Y; Wang Y; Wang H; Chen Z; Lou J; Xu H; Wang H; Qian W; Meng H; Lin M; Jin J
    Leukemia; 2009 Oct; 23(10):1801-6. PubMed ID: 19474801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.
    Marlton P; Keating M; Kantarjian H; Pierce S; O'Brien S; Freireich EJ; Estey E
    Leukemia; 1995 Jun; 9(6):965-71. PubMed ID: 7596186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain.
    Sierra M; Alonso A; Odero MD; Gonzalez MB; Lahortiga I; Pérez JJ; García JL; Gutiérrez NC; Calasanz MJ; San Miguel JF; Hernández JM
    Leuk Res; 2006 Aug; 30(8):943-8. PubMed ID: 16503352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
    Krauter J; Wagner K; Schäfer I; Marschalek R; Meyer C; Heil G; Schaich M; Ehninger G; Niederwieser D; Krahl R; Büchner T; Sauerland C; Schlegelberger B; Döhner K; Döhner H; Schlenk RF; Ganser A
    J Clin Oncol; 2009 Jun; 27(18):3000-6. PubMed ID: 19380453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
    Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
    Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation.
    Wei S; Wang S; Qiu S; Qi J; Mi Y; Lin D; Zhou C; Liu B; Li W; Wang Y; Wang M; Wang J
    Leuk Res; 2013 Sep; 37(9):1010-5. PubMed ID: 23800796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and cytogenetic features and their influencing factors of core binding factor acute myeloid leukemia].
    Li W; Mi YC; Liu BC; Zhou CL; Lin D; Wang HJ; Liu XP; Li QH; Bian SG; Wang JX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):517-24. PubMed ID: 22338135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and laboratory investigation of four acute myeloid leukemia patients with t(3;3) translocation].
    Chen ZM; Wu JG; Jin J; Lou JY; Lin MF
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):35-7. PubMed ID: 14990076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chromosomes, morphologic subtypes and their prognostic evaluation in acute non-lymphocytic leukemia].
    Fujita K; Takahashi N; Tada J; Higuchi T; Shimizu T; Harada H; Mori H; Niikura H; Omine M; Okada S
    Rinsho Ketsueki; 1995 Aug; 36(8):720-7. PubMed ID: 7563604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature.
    Betts DR; Rohatiner AZ; Evans ML; Rassam SM; Lister TA; Gibbons B
    Leukemia; 1992 Dec; 6(12):1250-6. PubMed ID: 1453770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
    Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
    Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
    Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
    Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetic manifestation of chromosome 11 duplication/amplification in acute myeloid leukemia.
    Sárová I; Brezinová J; Zemanová Z; Izáková S; Lizcová L; Malinová E; Berková A; Cermák J; Maaloufová J; Nováková L; Michalová K
    Cancer Genet Cytogenet; 2010 Jun; 199(2):121-7. PubMed ID: 20471515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia.
    Kalwinsky DK; Raimondi SC; Schell MJ; Mirro J; Santana VM; Behm F; Dahl GV; Williams D
    J Clin Oncol; 1990 Jan; 8(1):75-83. PubMed ID: 2295913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.